{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:24:17Z","timestamp":1791429857759,"version":"4.3.3"},"reference-count":201,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.addr.2012.10.005","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T19:16:36Z","timestamp":1351019796000},"page":"782-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells"],"prefix":"10.1016","volume":"65","author":[{"given":"Kwang-Chul","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nameirakpam D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Daniell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2012.10.005_bb0005","series-title":"Engaging communities to improve global health: reducing disease burden through collaborative approaches","year":"2010"},{"key":"10.1016\/j.addr.2012.10.005_bb0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tplants.2009.09.009","article-title":"Plant-made vaccine antigens and biopharmaceuticals","volume":"14","author":"Daniell","year":"2009","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.addr.2012.10.005_bb0015","first-page":"1552","article-title":"Recent advances in insulin delivery systems: an update","volume":"11","author":"Nitesh","year":"2010","journal-title":"World Appl. Sci. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0020","first-page":"117","article-title":"Evolving trends in insulin delivery: in pursuit of improvements in diabetes management","volume":"3","author":"Akhrass","year":"2010","journal-title":"AHDB"},{"key":"10.1016\/j.addr.2012.10.005_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/heapro\/dah110","article-title":"Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses","volume":"19","author":"Kermode","year":"2004","journal-title":"Health Promot. Int."},{"key":"10.1016\/j.addr.2012.10.005_bb0030","series-title":"Report of the SIGN 2010 meeting: annual meeting of the safe injection global network, Dubai","year":"2010"},{"key":"10.1016\/j.addr.2012.10.005_bb0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s11095-010-0314-4","article-title":"Progress towards a needle-free hepatitis B vaccine","volume":"28","author":"Lebre","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2012.10.005_bb0040","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1104\/pp.109.152017","article-title":"The role of heterologous chloroplast sequence elements in transgene integration and expression","volume":"152","author":"Ruhlman","year":"2010","journal-title":"Plant Physiol."},{"key":"10.1016\/j.addr.2012.10.005_bb0045","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1128\/IAI.73.12.8266-8274.2005","article-title":"Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge","volume":"73","author":"Koya","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0050","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1016\/j.vaccine.2004.01.069","article-title":"Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food\/feed crop","volume":"22","author":"Watson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nbt0802-843c","article-title":"Molecular strategies for gene containment in transgenic crops","volume":"20","author":"Daniell","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0060","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1073\/pnas.0702219104","article-title":"Transgene containment by maternal inheritance: effective or elusive?","volume":"104","author":"Daniell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/83559","article-title":"Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals","volume":"19","author":"De Cosa","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0070","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1104\/pp.105.063040","article-title":"Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation","volume":"138","author":"Quesada-Vargas","year":"2005","journal-title":"Plant Physiol."},{"key":"10.1016\/j.addr.2012.10.005_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymben.2011.11.005","article-title":"Remodeling the isoprenoid pathway in tobacco by expressing the cytoplasmic mevalonate pathway in chloroplasts","volume":"14","author":"Kumar","year":"2012","journal-title":"Metab. Eng."},{"key":"10.1016\/j.addr.2012.10.005_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1467-7652.2009.00479.x","article-title":"Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery","volume":"8","author":"Davoodi-Semiromi","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11103-011-9766-0","article-title":"Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts","volume":"76","author":"Kanagaraj","year":"2011","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.addr.2012.10.005_bb0090","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/IAI.00050-08","article-title":"Effective plague vaccination via oral delivery of plant cells expressing F1\u2013V antigens in chloroplasts","volume":"76","author":"Arlen","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1467-7652.2007.00259.x","article-title":"Expression of cholera toxin B\u2013proinsulin fusion protein in lettuce and tobacco chloroplasts \u2014 oral administration protects against development of insulitis in non-obese diabetic mice","volume":"5","author":"Ruhlman","year":"2007","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1467-7652.2010.00582.x","article-title":"Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide","volume":"9","author":"Boyhan","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1467-7652.2007.00258.x","article-title":"Field production and functional evaluation of chloroplast-derived interferon-alpha2b","volume":"5","author":"Arlen","year":"2007","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6750-9-33","article-title":"Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function","volume":"9","author":"Daniell","year":"2009","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1467-7652.2010.00538.x","article-title":"Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections","volume":"9","author":"Lee","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1467-7652.2011.00616.x","article-title":"Metallothionein expression in chloroplasts enhances mercury accumulation and phytoremediation capability","volume":"9","author":"Ruiz","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0125","doi-asserted-by":"crossref","unstructured":"K.C. Kwon, R. Nityanandam, J.S. New, H. Daniell, Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells, Plant Biotechnol. J. (in press), http:\/\/dx.doi.org\/10.1111\/pbi.12008.","DOI":"10.1111\/pbi.12008"},{"key":"10.1016\/j.addr.2012.10.005_bb0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.biotechadv.2011.07.018","article-title":"Delivery of plant-made vaccines and therapeutics","volume":"30","author":"Pelosi","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.addr.2012.10.005_bb0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbm.10019","article-title":"Uptake of poly (d,l-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo","volume":"60","author":"Newman","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.addr.2012.10.005_bb0140","series-title":"General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP)","author":"Kroger","year":"2011"},{"key":"10.1016\/j.addr.2012.10.005_bb0145","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Harper","year":"2005","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.addr.2012.10.005_bb0150","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/125.6.656","article-title":"A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity","volume":"125","author":"Ruben","year":"1972","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2012.10.005_bb0155","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1093\/infdis\/136.Supplement_3.S466","article-title":"The immunizing effect of influenza A\/New Jersey\/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults","volume":"136","author":"Brown","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2012.10.005_bb0160","first-page":"10","article-title":"L'intradermo-reaction a la tuberculine et son interpretation clinique","volume":"18","author":"Mantoux","year":"1910","journal-title":"Presse Med."},{"key":"10.1016\/j.addr.2012.10.005_bb0165","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0264-410X(97)00293-4","article-title":"Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine","volume":"16","author":"Nirmal","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2012.10.005_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.addr.2012.10.005_bb0180","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","article-title":"Current challenges in non-invasive insulin delivery systems: a comparative review","volume":"59","author":"Khafagy","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2012.10.005_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/157488507779422374","article-title":"Nasal drug delivery system-factors affecting and applications","volume":"2","author":"Jadhav","year":"2007","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/02652040400015403","article-title":"Nasal delivery of insulin using chitosan microspheres","volume":"21","author":"Varshosaz","year":"2004","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.addr.2012.10.005_bb0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10717540500309040","article-title":"Nasal delivery of insulin using bioadhesive chitosan gels","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2012.10.005_bb0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0939-6411(00)00144-2","article-title":"Factors and strategies for improving buccal absorption of peptides","volume":"51","author":"Veuillez","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2012.10.005_bb0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.04.012","article-title":"Buccal bioadhesive drug delivery \u2014 a promising option for orally less efficient drugs","volume":"114","author":"Sudhakar","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2012.10.005_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2078-7685.197963","article-title":"Emerging trends in insulin delivery: buccal route","volume":"2","author":"Kumria","year":"2011","journal-title":"J. Diabetol."},{"key":"10.1016\/j.addr.2012.10.005_bb0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1248\/cpb.50.749","article-title":"Phospholipid deformable vesicles for buccal delivery of insulin","volume":"50","author":"Yang","year":"2002","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.addr.2012.10.005_bb0220","first-page":"4842","article-title":"Study on nanoparticle system for buccal delivery of insulin","volume":"5","author":"Luo","year":"2005","journal-title":"Conf. Proc. IEEE Eng. Med. Biol."},{"key":"10.1016\/j.addr.2012.10.005_bb0225","first-page":"210","article-title":"Buccoadhesive tablets for insulin delivery: in vitro and in vivo studies","volume":"141","author":"Hosny","year":"2002","journal-title":"Boll. Chim. Farm."},{"key":"10.1016\/j.addr.2012.10.005_bb0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0250-474X.40333","article-title":"Design and in vitro characterization of buccoadhesive drug delivery system of insulin","volume":"70","author":"Sahni","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2012.10.005_bb0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.carbpol.2006.07.028","article-title":"Development of chitosan sponges for buccal administration of insulin","volume":"68","author":"Portero","year":"2007","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2012.10.005_bb0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1043661802002049","article-title":"Hypoglycaemic effect of a novel insulin buccal formulation on rabbits","volume":"46","author":"Xu","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2012.10.005_bb0245","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jbm.a.32071","article-title":"Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin","volume":"89","author":"Cui","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2012.10.005_bb0250","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/03639040902769628","article-title":"The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery","volume":"9","author":"Zhang","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2012.10.005_bb0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2009.05.008","article-title":"Insulin-micro- and nanoparticles for pulmonary delivery","volume":"377","author":"Klingler","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2012.10.005_bb0265","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/152091501300209606","article-title":"Overcoming skin's barrier: the search for effective and user-friendly drug delivery","volume":"3","author":"Prausnitz","year":"2001","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejcb.2010.07.010","article-title":"Tight junctions form a barrier in human epidermis","volume":"89","author":"Kirschner","year":"2010","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.addr.2012.10.005_bb0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2003.09.032","article-title":"Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers","volume":"269","author":"Pillai","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2012.10.005_bb0285","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/03639041003682012","article-title":"Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin","volume":"36","author":"Rastogi","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2012.10.005_bb0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-3659(02)00054-8","article-title":"Effect of sonication parameters on transdermal of insulin to hairless rats","volume":"81","author":"Boucaud","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2012.10.005_bb0295","first-page":"s12","article-title":"Advances in radio-frequency transdermal drug delivery","volume":"32","author":"Levin","year":"2008","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.addr.2012.10.005_bb0300","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/adma.200902418","article-title":"Drawing lithography: three dimensional fabrication of an ultrahigh-aspect-ratio microneedle","volume":"22","author":"Lee","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2012.10.005_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2008.0103","article-title":"Minimally invasive insulin delivery in subjects with type I diabetes using hollow microneedles","volume":"11","author":"Gupta","year":"2009","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0310","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1208\/s12249-011-9715-x","article-title":"Recovery of skin barrier after stratum corneum removal by microdermabrasion","volume":"12","author":"Andrews","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2012.10.005_bb0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"Weiner","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2012.10.005_bb0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jbiotec.2005.05.027","article-title":"Oral administration of a cholera toxin B subunit\u2013insulin fusion protein produced in silkworm protects against autoimmune diabetes","volume":"119","author":"Gong","year":"2005","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0330","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.cji.0000171315.82997.9a","article-title":"Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens","volume":"28","author":"Denes","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.addr.2012.10.005_bb0335","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.vaccine.2010.04.005","article-title":"Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism","volume":"28","author":"Gong","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0340","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0797-793","article-title":"Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance","volume":"3","author":"Ma","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2012.10.005_bb0345","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1073\/pnas.0307420101","article-title":"Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4","volume":"101","author":"Ma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0350","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1073\/pnas.0503428102","article-title":"A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses","volume":"102","author":"Takagi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0355","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1467-7652.2011.00613.x","article-title":"Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression","volume":"9","author":"Suzuki","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0360","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.vaccine.2008.09.019","article-title":"Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed","volume":"26","author":"Takagi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0365","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0370","first-page":"34","article-title":"Intranasal drug delivery system \u2014 a glimpse to become maestro","volume":"1","author":"Upadhyay","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.addr.2012.10.005_bb0375","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2004121026","article-title":"Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat","volume":"16","author":"Reynolds","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2012.10.005_bb0380","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar2403","article-title":"Mucosal administration of alpha-fodrin inhibits experimental Sj\u00f6gren's syndrome autoimmunity","volume":"10","author":"He","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00296-008-0634-4","article-title":"Mucosal administration of an altered CII263\u2013272 peptide inhibits collagen-induced arthritis by suppression of Th1\/Th17 cells and expansion of regulatory T cells","volume":"29","author":"Zhao","year":"2008","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.addr.2012.10.005_bb0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2005-11-4668","article-title":"Immune deviation by mucosal antigen administration suppresses gene-transfer- induced inhibitor formation to factor IX","volume":"108","author":"Cao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.addr.2012.10.005_bb0395","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/j.1538-7836.2006.02118.x","article-title":"Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain","volume":"4","author":"Rawle","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.addr.2012.10.005_bb0400","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4049\/jimmunol.179.4.2082","article-title":"Altered B:9\u201323 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes","volume":"179","author":"Kobayashi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0405","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/08820130903124770","article-title":"Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides","volume":"38","author":"Wang","year":"2009","journal-title":"Immunol. Invest."},{"issue":"9","key":"10.1016\/j.addr.2012.10.005_bb0410","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1023\/B:PHAM.0000041443.17935.33","article-title":"Novel approaches to vaccine delivery","volume":"21","author":"O'Hagan","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2012.10.005_bb0415","series-title":"Mucosal Immunology","first-page":"485","article-title":"Mucosal immune responses: an overview","author":"McGhee","year":"1999"},{"key":"10.1016\/j.addr.2012.10.005_bb0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"MacPherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb1040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0435","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.1700290113","article-title":"The number of lymphoid follicles of the human large intestine","volume":"29","author":"Dukes","year":"1926","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2012.10.005_bb0440","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni1101-1004","article-title":"Collaboration of epithelial cells with organized mucosal lymphoid tissues","volume":"2","author":"Neutra","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0445","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system: from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0450","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1399-0039.1997.tb02916.x","article-title":"Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine","volume":"50","author":"Martin-Villa","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.addr.2012.10.005_bb0455","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1006\/cyto.1999.0731","article-title":"Lens culinaris, Phaseolus vulgaris and Vicia faba lectins specifically trigger IL-8 production by the human colon carcinoma cell line CACO-2","volume":"12","author":"Rodriguez-Juan","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.addr.2012.10.005_bb0460","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1054\/tice.2001.0212","article-title":"Cell surface phenotype andcytokine secretion in Caco-2 cell cultures: increased RANTES production and IL-2 transcription upon stimulation with IL-1beta","volume":"33","author":"Rodriguez-Juan","year":"2001","journal-title":"Tissue Cell"},{"key":"10.1016\/j.addr.2012.10.005_bb0465","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1574-695X.2000.tb01444.x","article-title":"Modulation of immune responses following antigen administration by mucosal route","volume":"27","author":"Medina","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2012.10.005_bb0470","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"Nochi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0475","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.plantsci.2011.01.004","article-title":"Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice","volume":"180","author":"Amani","year":"2011","journal-title":"Plant Sci."},{"key":"10.1016\/j.addr.2012.10.005_bb0480","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymeth.2005.09.013","article-title":"Mucosal immunization using recombinant plant-based oral vaccines","volume":"38","author":"Streatfield","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.addr.2012.10.005_bb0485","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1128\/JVI.76.15.7506-7517.2002","article-title":"Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing Human immunodeficiency virus type 1 Gag and Env proteins","volume":"76","author":"Haglund","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2012.10.005_bb0490","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2012.02.072","article-title":"Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen","volume":"30","author":"Hayden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0495","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0684.2005.00120.x","article-title":"Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate","volume":"34","author":"Pal","year":"2005","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.addr.2012.10.005_bb0500","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/10611869609015965","article-title":"Nasal delivery of vaccines","volume":"3","author":"Almeida","year":"1996","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2012.10.005_bb0505","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.14.1.275","article-title":"Antigen sampling across epithelial barriers and induction of mucosal immune responses","volume":"14","author":"Neutra","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0510","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1165\/rcmb.2002-0230OC","article-title":"Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes","volume":"30","author":"Jahnsen","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.addr.2012.10.005_bb0515","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/14712598.3.3.519","article-title":"Nasal drug delivery","volume":"3","author":"Suman","year":"2003","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0520","doi-asserted-by":"crossref","first-page":"e13972","DOI":"10.1371\/journal.pone.0013972","article-title":"Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2012.10.005_bb0525","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1016\/j.vaccine.2011.04.094","article-title":"Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice","volume":"29","author":"Madhun","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0530","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni0603-503","article-title":"TH1\u2013TH2: a procrustean paradigm","volume":"4","author":"Gor","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0535","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0540","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0545","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0550","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/289597","article-title":"Cytokines: the future of intranasal vaccine adjuvants","volume":"2011","author":"Thompson","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0555","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1096\/fj.05-5134fje","article-title":"Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system","volume":"20","author":"Limaye","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2012.10.005_bb0560","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1104\/pp.107.106690","article-title":"Chloroplast vector systems for biotechnology applications","volume":"145","author":"Verma","year":"2007","journal-title":"Plant Physiol."},{"key":"10.1016\/j.addr.2012.10.005_bb0565","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1073\/pnas.0912181107","article-title":"Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice","volume":"107","author":"Verma","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0570","first-page":"4","article-title":"Drug delivery in diabetes: making effective treatment tolerable, ONdrugDelivery","author":"Patel","year":"2006"},{"key":"10.1016\/j.addr.2012.10.005_bb0575","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00125-006-0559-y","article-title":"C-peptide is a bioactive peptide","volume":"50","author":"Wahren","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.addr.2012.10.005_bb0580","series-title":"Insulin delivery systems market forecast to 2014","year":"2012"},{"key":"10.1016\/j.addr.2012.10.005_bb0585","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2010.06.003","article-title":"Peptide drugs to target G protein-coupled receptors","volume":"31","author":"Bellmann-Sickert","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2012.10.005_bb0590","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coph.2008.06.002","article-title":"Discovering and improving novel peptide therapeutics","volume":"8","author":"McGregor","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.addr.2012.10.005_bb0595","series-title":"The future of peptide development in the pharmaceutical industry, PharManufacturing","author":"Lax","year":"2012"},{"key":"10.1016\/j.addr.2012.10.005_bb0600","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2036.2007.03470.x","article-title":"Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients","volume":"26","author":"Diago","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0605","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/138920106777950852","article-title":"Novel delivery technologies for protein and peptide therapeutics","volume":"7","author":"Kumar","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0610","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.2337\/diabetes.53.9.2492","article-title":"A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis","volume":"53","author":"Baggio","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2012.10.005_bb0615","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/nbt1364","article-title":"Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic Hepatitis C","volume":"25","author":"Subramanian","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0620","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs","volume":"30","author":"Werle","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.addr.2012.10.005_bb0625","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1096\/fj.02-0831rev","article-title":"Curbing activation: proprotein convertases in homeostasis and pathology","volume":"17","author":"Taylor","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2012.10.005_bb0630","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/pr.108.000604","article-title":"The role of incretins in glucose homeostasis and diabetes treatment","volume":"60","author":"Kim","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2012.10.005_bb0635","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.addr.2012.10.005_bb0640","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrd1828","article-title":"Exenatide","volume":"4","author":"Davidson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2012.10.005_bb0645","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00281-010-0208-x","article-title":"The pancrease in human type 1 diabetes","volume":"33","author":"Rowe","year":"2011","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.addr.2012.10.005_bb0650","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2007.11.005","article-title":"Insulin as an autoantigen in NOD\/human diabetes","volume":"20","author":"Zhang","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0655","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/9442","article-title":"The NOD mouse model of type 1 diabetes: as good as it gets?","volume":"5","author":"Atkinson","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2012.10.005_bb0660","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2010.04.002","article-title":"Immunotherapy of type 1 diabetes: where are we and where should we be going?","volume":"32","author":"Luo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2012.10.005_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2009.02321.x","article-title":"Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit","volume":"71","author":"Sun","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0670","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.268","article-title":"Clinical utility gene card for: Haemophilia B","volume":"20","author":"Jenkins","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.addr.2012.10.005_bb0675","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1160\/TH11-03-0193","article-title":"Haemophilia B: impact on patients and economic burden of disease","volume":"106","author":"Gater","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.addr.2012.10.005_bb0680","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.2007.06657.x","article-title":"Inhibitor development in Haemophilia B: an orphan disease in need of attention","volume":"138","author":"DiMichele","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.addr.2012.10.005_bb0685","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12016-009-8118-1","article-title":"Immune response to FVIII in hemophilia A: an overview of risk factors","volume":"37","author":"Ghosh","year":"2009","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2012.10.005_bb0690","first-page":"S20","article-title":"Development of inhibitors in haemophilia. Ongoing epidemiological study","volume":"31","author":"Serban","year":"2011","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.addr.2012.10.005_bb0695","article-title":"Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice","volume":"19","author":"Benson","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.addr.2012.10.005_bb0700","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0705","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis \u2014 etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2012.10.005_bb0710","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management, Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2012.10.005_bb0715","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0725","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biotechadv.2009.11.006","article-title":"Prevention of bubonic and pneumonic plague using plant-derived vaccines","volume":"28","author":"Alvarez","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.addr.2012.10.005_bb0730","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2249.2007.03452.x","article-title":"The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses","volume":"149","author":"Kingston","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0735","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.0510014103","article-title":"Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system","volume":"103","author":"Santi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0740","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2007.01.017","article-title":"A plant-produced plague vaccine candidate confers protection to monkeys","volume":"25","author":"Mett","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0745","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.vaccine.2009.01.050","article-title":"A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague","volume":"27","author":"Chichester","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0750","unstructured":"http:\/\/www.who.int\/immunization\/Cholera_PP_Accomp_letter_Mar_10_2010.pdf. Cholera vaccines. A brief summary of the March 2010 position paper, 2010."},{"key":"10.1016\/j.addr.2012.10.005_bb0755","first-page":"CD008603","article-title":"Oral vaccines for preventing cholera","volume":"3","author":"Sinclair","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2012.10.005_bb0760","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.4.2.5122","article-title":"Cholera vaccines for the developing world","volume":"4","author":"Lopez","year":"2008","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.addr.2012.10.005_bb0765","series-title":"Is a vaccine available to prevent cholera?","year":"2011"},{"key":"10.1016\/j.addr.2012.10.005_bb0770","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14760584.5.6.751","article-title":"Present and future cholera vaccines","volume":"5","author":"Olsson","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2012.10.005_bb0775","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2012.10.005_bb0780","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1440-1711.1998.00745.x","article-title":"The role of ADP-ribosylation and GM1-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin","volume":"76","author":"de Haan","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.addr.2012.10.005_bb0785","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1348-0421.1995.tb03262.x","article-title":"Monomer of the B subunit of heat-labile enterotoxin from enterotoxigenic Escherichia coli has little ability to bind to GM1 ganglioside compared to its coligenoid","volume":"39","author":"Tsuji","year":"1995","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0790","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/gut.45.5.633","article-title":"Vaccines against gut pathogens","volume":"45","author":"Mastroeni","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.addr.2012.10.005_bb0795","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm0598-607","article-title":"Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato","volume":"4","author":"Tacket","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2012.10.005_bb0800","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00299-011-1146-3","article-title":"Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea","volume":"31","author":"Karaman","year":"2012","journal-title":"Plant Cell Rep."},{"key":"10.1016\/j.addr.2012.10.005_bb0805","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.4049\/jimmunol.0901480","article-title":"A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity","volume":"183","author":"Nochi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0810","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.vaccine.2004.11.004","article-title":"(2005) Chloroplast-derived vaccine antigens and other therapeutic proteins","volume":"23","author":"Daniell","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0815","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1006\/jmbi.2001.4921","article-title":"Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts","volume":"311","author":"Daniell","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2012.10.005_bb0820","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1467-7652.2006.00234.x","article-title":"Stable expression of Gal\/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis","volume":"5","author":"Chebolu","year":"2007","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.addr.2012.10.005_bb0830","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(03)00077-X","article-title":"Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-142 malaria vaccine","volume":"128","author":"Angov","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.addr.2012.10.005_bb0835","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pt.2006.05.002","article-title":"Progress towards the development of malaria vaccines","volume":"22","author":"Malkin","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2012.10.005_bb0840","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1016\/j.vaccine.2008.09.081","article-title":"A phase 1 trial of PfCP2.9: an AMA1\/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria","volume":"26","author":"Malkin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0845","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/adc.2005.092551","article-title":"Towards an effective malaria vaccine","volume":"92","author":"Aide","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.addr.2012.10.005_bb0850","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(05)66420-3","article-title":"Malaria","volume":"365","author":"Greenwood","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2012.10.005_bb0855","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/4511042a","article-title":"Malaria: the end of the beginning","volume":"451","author":"Maher","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.addr.2012.10.005_bb0860","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.16.1.57","article-title":"Pathways and strategies for developing a malaria blood-stage vaccine","volume":"16","author":"Good","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0865","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pt.2007.12.002","article-title":"Apical membrane antigen 1: a malaria vaccine candidate in review","volume":"24","author":"Remarque","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2012.10.005_bb0870","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1073\/pnas.2032858100","article-title":"Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites","volume":"100","author":"Dutta","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb0875","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","article-title":"Specificity of the Protective Antibody Response to Apical Membrane Antigen 1","volume":"69","author":"Hodder","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0880","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/IAI.68.4.1964-1966.2000","article-title":"Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acid","volume":"68","author":"Narum","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0885","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.172.1.379","article-title":"A single fragment of a malaria meroxoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies","volume":"172","author":"Blackman","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2012.10.005_bb0890","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/IAI.64.1.253-261.1996","article-title":"A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria","volume":"64","author":"Chang","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0895","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/IAI.73.1.287-297.2005","article-title":"The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites","volume":"73","author":"Darko","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0900","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/IAI.68.3.1418-1427.2000","article-title":"Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed and\/or -rechallenged Aotus vociferons monkeys","volume":"68","author":"Egan","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0905","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1128\/IAI.65.8.3032-3036.1997","article-title":"Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii","volume":"65","author":"Tian","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2012.10.005_bb0910","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpara.2007.06.005","article-title":"Immunogenicity of Plasmodium yoelii merozoite surface protein 4\/5 produced in transgenic plants","volume":"38","author":"Wang","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.addr.2012.10.005_bb0915","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.vaccine.2005.11.041","article-title":"Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants","volume":"24","author":"Sachdeva","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb0920","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt0210-107","article-title":"Pfizer stakes a claim in plant cell-made biopharmaceuticals","volume":"28","author":"Ratner","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0930","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2012.10.005_bb0935","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2012.10.005_bb0940","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.addr.2012.10.005_bb0945","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity \u2014 friends or foes?","volume":"30","author":"Kivity","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0950","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.1099896","article-title":"Immune therapy for autoimmune diseases","volume":"305","author":"Steinman","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.addr.2012.10.005_bb0955","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nbt.1484","article-title":"Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment","volume":"26","author":"Wang","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb0960","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2012.03.009","article-title":"Mapping the T helper cell response to acid \u03b1-glucosidase in Pompe mice","volume":"106","author":"Nayak","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.addr.2012.10.005_bb0965","first-page":"005","article-title":"Hemophilia: disease, diagnosis and treatment","volume":"S1","author":"Jayandharan","year":"2011","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0970","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/mt.2009.159","article-title":"Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B","volume":"17","author":"Cao","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2012.10.005_bb0975","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.133.4.1818","article-title":"Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response","volume":"133","author":"McKenzie","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb0980","first-page":"89","article-title":"Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice","volume":"72","author":"Van der Heijden","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2012.10.005_bb0985","first-page":"153","article-title":"Cholera toxin \u2014 a foe & a friend","volume":"133","author":"S\u00e1nchez","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.addr.2012.10.005_bb0990","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.imbio.2010.09.008","article-title":"Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit","volume":"216","author":"Odumosu","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.addr.2012.10.005_bb0995","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1016\/j.vaccine.2011.07.077","article-title":"Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function","volume":"29","author":"Odumosu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2012.10.005_bb1000","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","article-title":"Oral tolerization with peptide 336\u2013351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease","volume":"137","author":"Stanford","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2012.10.005_bb1005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea","volume":"28","author":"Kendall","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.addr.2012.10.005_bb1010","author":"Eli Lilly (Netherlands)"},{"key":"10.1016\/j.addr.2012.10.005_bb1015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/gut.8.6.618","article-title":"Surface area of the small intestine in man","volume":"8","author":"Wilson","year":"1967","journal-title":"Gut"},{"key":"10.1016\/j.addr.2012.10.005_bb1020","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.72.7.2520","article-title":"Interaction of cholera toxin and membrane GM1 ganglioside of small intestine","volume":"72","author":"Holmgren","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2012.10.005_bb1025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-2275(20)37914-1","article-title":"Uptake and metabolism of exogenous gangliosides by cultured cells: effect of choleragen on the turnover of GM1","volume":"24","author":"Fishman","year":"1983","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.addr.2012.10.005_bb1030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0958-1669(02)00284-7","article-title":"Protein transduction technology","volume":"13","author":"Wadia","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2012.10.005_bb1035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.addr.2011.12.014","article-title":"Oral biodrug delivery using cell-penetrating peptide","volume":"64","author":"Khafagy","year":"2012","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X12003237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X12003237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:18:16Z","timestamp":1745036296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X12003237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":201,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0169409X12003237"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2012.10.005","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2012.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}